NCT05184712 2026-03-04Phase 3 Clinical Study of AK112 for NSCLC PatientsAkesoPhase 3 Active not recruiting322 enrolled
NCT04293562 2026-02-24A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsChildren's Oncology GroupPhase 3 Recruiting1,186 enrolled
NCT07424287 2026-02-20A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBCSuzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 3 Not yet recruiting236 enrolled
NCT07418749 2026-02-18A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical CancerSuzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 3 Not yet recruiting398 enrolled